Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Home  Sitemap  Imprint

Frederick Frank - biography

Fred Frank, Vice Chairman and Director, Lehman Brothers is a veteran and experienced specialist in investment banking services for companies in the pharmaceutical, biotechnology, medical devices, and healthcare services industries. He has managed hundreds of financing/M&A transactions in the healthcare sector including the Bristol-Myers Squibb merger, the Roche/Genentech merger, the IPO of Applied Biosystems, the HGS/ SmithKline- Beecham Collaboration, the merger of Synthelabo and Sanofi, the acquisition by Glaxo of Affymax, as well as the acquisition of Allergan by SmithKline Beecham, and most recently the acquisition of Diagnostic Products by Siemens and the acquisition of Rinat Neurosciences by Pfizer.

< back